Abstract
Backgroundthe evaluation of disease activity in patients with polymyositis (PM) and dermatomyositis (DM) still represents a challenge. International Myositis Assessment & Clinical Studies Group (IMACS) has performed a consensus on...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
